Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Naifu Nie"'
Autor:
Yidan Ye, Chuyue Xiong, Yang Dai, Yan Wang, Xinyue Yang, Lixia Cheng, Chao Hou, Naifu Nie, Huan Tang, Xiangyu Ma, Anqiang Zhang, Guoqiang Cao, Yong He, Ji Jiang, Li Li
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Fatigue is a common symptom of long COVID syndrome. Compared to male survivors, females have a higher incidence of post-COVID fatigue. Therefore, long-term follow-up is necessary to understand which groups of females are more vuln
Externí odkaz:
https://doaj.org/article/48689073fddf4d03b669dc197c84f01c
Autor:
Naifu Nie, Haodong Zhou, Kejun Zhang, Lan liu, Nuo Luo, Renyuan Wang, Xin Li, Mengxiao Zhu, Chen Hu, Yubo Wang, Zhulin Liu, Li Li, Yong He
Publikováno v:
Thoracic Cancer, Vol 13, Iss 18, Pp 2574-2583 (2022)
Abstract Background The prognosis of non–small‐cell lung cancer (NSCLC) with leptomeningeal metastasis (LM) is poor. Detection of cell‐free DNA (cfDNA) by next generation sequencing (NGS) in cerebrospinal fluid (CSF) may facilitate diagnosis of
Externí odkaz:
https://doaj.org/article/9f38c3c1e4904f3c97d0cc4f42ee0580
Autor:
Naifu Nie, Jianghua Li, Jian Zhang, Jie Dai, Zhulin Liu, Zhenyu Ding, Yubo Wang, Mengxiao Zhu, Chen Hu, Rui Han, Huan Tang, Li Li, Yong He
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 16 (2022)
Background: Although the clinical application of osimertinib, a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), has been a new step forward in the first-line treatment of non-small cell lung cancer (NSCLC), an
Externí odkaz:
https://doaj.org/article/06ff200363b7492fa950dee683d1d333
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-4 (2021)
Abstract Background Capillary hemangioma can be found in many organs, but rarely in pleura. Previously, only localized pleural capillary hemangioma cases have been reported. Corticosteroids are the most commonly recommended drugs in capillary hemangi
Externí odkaz:
https://doaj.org/article/dfbb574b6f4440fea1cc9e30d157b5fb
Autor:
Ying Zhang, Zhaojie Han, Yang Dai, Yuhui Liu, Qinghua Wang, Lixia Cheng, Chuyue Xiong, Chao Hou, Xinyue Yang, Yidan Ye, Qian Zhao, Naifu Nie, Xiangyu Ma, Huan Tang, Anqiang Zhang, Zhenhong Hu, Guoqiang Cao, Paul Jones, Jianxin Jiang, Ling Zeng
Publikováno v:
Aging & Disease; Nov2023, Vol. 14 Issue 6, p2238-2248, 11p
Autor:
Li Li, Yong He, Ling Zeng, Jianxin Jiang, Paul Jones, Guoqiang Cao, Zhenhong Hu, Anqiang Zhang, Huan Tang, Xiangyu Ma, Naifu Nie, Qian Zhao, Yidan Ye, Xinyue Yang, Chao Hou, Chuyue Xiong, Lixia Cheng, Qinghua Wang, Yuhui Liu, Yang Dai, Zhaojie Han, Ying Zhang
Publikováno v:
Aging and disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e3aed41d993f23214b80e2f39d53436
https://doi.org/10.14336/ad.2023.0304
https://doi.org/10.14336/ad.2023.0304
Autor:
Fuqiang Wen, Fenfen Sun, Dong Luo, Jinping Zheng, Bin Sun, Shisi Zhang, Ye Shen, Qian Zhao, Yong He, Li Li, Binfeng He, Zhen Qin, Kui Wu, Naifu Nie, Paul W. Jones, Xiangyu Ma, Guoqiang Cao, Na-na Zhao, Xingsheng Wang
Publikováno v:
Chest. 160:1660-1669
Background Systemic corticosteroids for the treatment of COPD exacerbations decrease treatment failure and shorten the length of hospitalization. However, the optimal dose is unclear. Research Question Is personalized-dose corticosteroid administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e96f99bd2662fed22534ececb6d883a0
https://doi.org/10.1016/j.chest.2021.05.024
https://doi.org/10.1016/j.chest.2021.05.024
Publikováno v:
Annals of Palliative Medicine. 10:210-219
Background Immune checkpoint inhibitors (ICIs) have become the standard treatment for patients with advanced non-small cell lung cancer (NSCLC). However, the safety and efficacy of ICIs in severe advanced NSCLC patients with poor performance status (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f81a46f2bcae6e88a80136500944b574
https://doi.org/10.21037/apm-20-2279
https://doi.org/10.21037/apm-20-2279
Both crizotinib and ceritinib are recommended as first-line theray for NSCLC with ROS1 rearrangements, with the latter having stronger infiltration ability across blood-brain barrier. Here we report for the first time that a brain metastatic adenocar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::175c87386f2e756faa96785c70d4c608
https://doi.org/10.21203/rs.3.rs-882880/v1
https://doi.org/10.21203/rs.3.rs-882880/v1
Publikováno v:
BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-4 (2021)
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-4 (2021)
Background Capillary hemangioma can be found in many organs, but rarely in pleura. Previously, only localized pleural capillary hemangioma cases have been reported. Corticosteroids are the most commonly recommended drugs in capillary hemangioma. Case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d456ffce4e2b73dfbec1157da2b77598
https://pubmed.ncbi.nlm.nih.gov/33971849
https://pubmed.ncbi.nlm.nih.gov/33971849